1.Application of rehabilitation therapy techniques for post-stroke dysphagia: a bibliometric analysis
Ping LIU ; Nan ZHOU ; Xiaojie XUE ; Weibo SHAO
Chinese Journal of Rehabilitation Theory and Practice 2026;32(3):294-303
ObjectiveTo analyze the current status, hotspot and development trends of rehabilitation technologies for post-stroke dysphagia (PSD). MethodsLiteratures related to rehabilitation technologies for PSD were retrieved from CNKI, VIP and Web of Science Core Collection from inception to July, 2025. Visualization analysis was conducted using CiteSpace 6.3.R1 and VOSviewer 1.2.20. ResultsA total of 1 265 articles were included, consisting of 794 Chinese and 471 English publications. The annual volume of Chinese literature peaked in 2019 (74 articles) and English literature peaked in 2022 (61 articles). Research hotspots included low-frequency surface neuromuscular electrical stimulation, repetitive transcranial magnetic stimulation, surface electromyography biofeedback and transcranial direct current stimulation. Keyword clustering and timeline analysis indicated that researches evolved from early traditional rehabilitation methods to the diversified and integrated application of combined rehabilitation technologies. ConclusionResearch on rehabilitation technologies for PSD is developing rapidly. Future efforts should focus on researches of multi-technology integration, individualized treatment protocols and long-term efficacy assessments.
2.Application of rehabilitation therapy techniques for post-stroke dysphagia: a bibliometric analysis
Ping LIU ; Nan ZHOU ; Xiaojie XUE ; Weibo SHAO
Chinese Journal of Rehabilitation Theory and Practice 2026;32(3):294-303
ObjectiveTo analyze the current status, hotspot and development trends of rehabilitation technologies for post-stroke dysphagia (PSD). MethodsLiteratures related to rehabilitation technologies for PSD were retrieved from CNKI, VIP and Web of Science Core Collection from inception to July, 2025. Visualization analysis was conducted using CiteSpace 6.3.R1 and VOSviewer 1.2.20. ResultsA total of 1 265 articles were included, consisting of 794 Chinese and 471 English publications. The annual volume of Chinese literature peaked in 2019 (74 articles) and English literature peaked in 2022 (61 articles). Research hotspots included low-frequency surface neuromuscular electrical stimulation, repetitive transcranial magnetic stimulation, surface electromyography biofeedback and transcranial direct current stimulation. Keyword clustering and timeline analysis indicated that researches evolved from early traditional rehabilitation methods to the diversified and integrated application of combined rehabilitation technologies. ConclusionResearch on rehabilitation technologies for PSD is developing rapidly. Future efforts should focus on researches of multi-technology integration, individualized treatment protocols and long-term efficacy assessments.
3.Application of rehabilitation therapy techniques for post-stroke dysphagia: a bibliometric analysis
Ping LIU ; Nan ZHOU ; Xiaojie XUE ; Weibo SHAO
Chinese Journal of Rehabilitation Theory and Practice 2026;32(3):294-303
ObjectiveTo analyze the current status, hotspot and development trends of rehabilitation technologies for post-stroke dysphagia (PSD). MethodsLiteratures related to rehabilitation technologies for PSD were retrieved from CNKI, VIP and Web of Science Core Collection from inception to July, 2025. Visualization analysis was conducted using CiteSpace 6.3.R1 and VOSviewer 1.2.20. ResultsA total of 1 265 articles were included, consisting of 794 Chinese and 471 English publications. The annual volume of Chinese literature peaked in 2019 (74 articles) and English literature peaked in 2022 (61 articles). Research hotspots included low-frequency surface neuromuscular electrical stimulation, repetitive transcranial magnetic stimulation, surface electromyography biofeedback and transcranial direct current stimulation. Keyword clustering and timeline analysis indicated that researches evolved from early traditional rehabilitation methods to the diversified and integrated application of combined rehabilitation technologies. ConclusionResearch on rehabilitation technologies for PSD is developing rapidly. Future efforts should focus on researches of multi-technology integration, individualized treatment protocols and long-term efficacy assessments.
4.Syndrome Differentiation and Treatment of Stress Urinary Incontinence from the Perspectives of the Lungs,Kidneys,and Heart
Yaoxing ZHOU ; Kuiqing SHAO ; Zhan GAO
Journal of Traditional Chinese Medicine 2026;67(4):456-460
This article discusses the syndrome differentiation and treatment of stress urinary incontinence from the perspectives of the lungs, kidneys, and heart. It is suggested that the initial stage of the disease is marked by the dysfunction of the lung and the disorder of qi movement, while the intermediate stage is characterized by the obstruction of qi movement and the instability of the kidney, and the advanced stage is characterized by the depletion of the kidney and the disturbance of the spirit. According to the characteristics of the disease and the changes in the pathogenesis, the methods are recommended including regulating the lung, boosting qi and governing water, nourishing the kidney and enriching essence, and calming the mind and soothing the spirit. Accordingly, self-designed prescriptions such as Shenqi Lifei Decoction(参芪利肺汤), Yiqi Gupao Decoction(益气固脬汤), and Yishen Shenning Decoction(益肾神宁汤)with modifications can be used to regulate the lungs, adjust the kidneys, and calm the mind, thereby achieving the treatment of stress urinary incontinence from the perspectives of the lungs, kidneys, and heart.
5.Clinical observation of sacubitril/valsartan versus benazepril in perimenopausal hypertensive patients
Xiaoxia ZHANG ; Bolin SHAO ; Yingkun ZHOU ; Zhanhai ZHANG ; Zhiying LI
China Pharmacy 2026;37(4):476-479
OBJECTIVE To compare the antihypertensive efficacy of sacubitril/valsartan versus benazepril in patients with perimenopausal hypertension, as well as their impacts on ventricular remodeling and inflammatory fibrosis. METHODS A total of 206 perimenopausal hypertensive patients in our hospital from January 1, 2023 to December 30, 2024 were retrospectively included.These patients were enrolled and divided into benazepril group (105 cases) and sacubitril/valsartan group (101 cases). Benazepril group received Benazepril hydrochloride tablet, and sacubitril/valsartan group received Sacubitril valsartan sodium tablet. All patients were treated for 6 months. The blood pressure(systolic blood pressure and diastolic blood pressure) and blood pressure control status before and after treatment, echocardiographic indicators (left ventricular ejection fraction, left ventricular mass index, relative wall thickness, and early-diastolic peak transmitral flow velocity/early-diastolic peak velocity of the mitral annulus), inflammatory fibrosis related indicators(high-sensitivity C-reactive protein,ratio of monocytes to lymphocytes,and ratio of neutrophils to lymphocytes), as well as the occurrence of adverse reactions(hypotension,hyperkalemia,and angioedema) were observed in both groups before and after treatment. RESULTS The blood pressure control rate was significantly higher in the sacubitril/valsartan group than in benazepril group ( P <0.05). After treatment, the blood pressure, echocardiographic indicators(except for left ventricular ejection fraction) ,and inflammatory fibrosis related indicators were significantly lower than those before treatment within the same group, and the sacubitril/valsartan group were significantly lower than the benazepril group ( P <0.05). There were no statistically significant differences in the incidence of hypotension, hyperkalemia, angioedema, and overall adverse drug reactions between the two groups ( P >0.05). CONCLUSIONS Compared with benazepril, sacubitril/valsartan provides superior blood-pressure control, reverses ventricular remodeling, attenuates inflammatory fibrosis in perimenopausal hypertensive patients, while maintaining a similar safety profile.
6.Clinical Efficacy and Radiographic Outcomes of Manipulative Reduction Combined with Small Splint Fixation for Distal Radius Fractures:A Retrospective Multicenter Study with Propensity Score Matching
Mao WU ; Guoda DAI ; Yang SHAO ; Shaoshuo LI ; Zhen HUA ; Hengyan CUI ; Tingchen ZHU ; Dipeng LI ; Jintao LIU ; Ming ZHOU ; Peimin WANG ; Liyong ZHANG ; Jianwei WANG
Journal of Traditional Chinese Medicine 2026;67(10):1086-1092
ObjectiveTo observe the clinical efficacy and radiographic outcomes of manipulative reduction combined with small splint fixation in the treatment of distal radius fractures. MethodsThe clinical data of 1051 patients with distal radius fractures were retrospectively collected from five hospitals included in the Jiangsu Diagnosis and Treatment Data Platform for Traditional Chinese Medicine(TCM) Dominant Diseases. Propensity score matching at a 1∶4 ratio was applied, resulting in 580 cases selected for final analysis, which comprised 448 patients in the TCM group(manipulative reduction plus small splint fixation) and 132 in the surgical treatment group(open reduction and internal fixation). Each group was further stratified into type A, B, and C subgroups based on AO fracture classification. Radiographic indicators including palmar tilt, radial inclination, and radial height were compared between groups before treatment and 1 day, 1 week, and 4-6 weeks after treatment, and pain visual analog scale(VAS) scores before treatment and 1 week and 4-6 weeks after treatment were also compared. Wrist joint function was assessed 12 weeks after treatment, using the Dienst wrist function score and the Gartland and Werley(G-W) wrist function score. Additionally, the radiographic indicators at different timepoints and the 12-week wrist function levels were compared between groups across different fracture types. ResultsNo statistically significant difference was observed in radiographic indicators and VAS scores at all timepoints before and after treatment, as well as wrist joint function grades assessed by the Dienst score and the G-W score at 12 weeks after treatment (P>0.05). Compared to those before treatment, both groups showed increased palmar tilt, radial inclination, and radial height 1 week and 4-6 weeks after treatment, and decreased VAS scores (P<0.05). Compared to those 1 week after treatment, both groups showed a decrease in palmar tilt, an increase in radial inclination and radial height, and a reduction in VAS score 4-6 weeks after treatment(P<0.05). In type A and B subgroups, the surgical treatment group had a higher radial inclination than the TCM group 4-6 weeks after treatment, while in the type C subgroup, a higher radial height was shown in the surgical treatment group than in the TCM group 4-6 weeks after treatment(P<0.05). In type C subgroup, there was significant difference between groups in the wrist joint function by G-W scores 12 weeks after treatment(P<0.05). ConclusionManipulative reduction combined with small splint fixation can maintain fracture alignment and alleviate pain in treating distal radius fractures, which achieves therapeutic outcomes comparable to surgical treatment. It is particularly suitable for type A and B fractures and can be considered an effective treatment option for distal radius fractures.
7.Construction and Clinical Validation of a Deep Learning-Based Automatic Measurement Model for Palmar Tilt and Radial Inclination in Distal Radius Fractures
Guoda DAI ; Jianwei WANG ; Mao WU ; Bin KANG ; Yang SHAO ; Hengyan CUI ; Shaoshuo LI ; Tingchen ZHU ; Zhen HUA ; Zhongming SHEN ; Jintao LIU ; Ming ZHOU
Journal of Traditional Chinese Medicine 2026;67(10):1093-1100
ObjectiveTo construct an automatic measurement model for palmar tilt and radial inclination suitable for traditional Chinese medicine (TCM) clinical scenarios, and to validate its accuracy and efficiency in TCM manipulative reduction settings. MethodsData on anteroposterior (AP) and lateral X-rays of distal radius fractures were collected from patients admitted to 18 TCM/ integrated TCM and western medicine hospitals in Jiangsu province between September 1st, 2023, and September 1st, 2024, via the Jiangsu Diagnosis and Treatment Big Data Platform for TCM Dominant Diseases. A medical image segmentation framework based on multi-scale feature fusion and edge-awareness was employed, combined with anatomical knowledge specific to TCM orthopedics, to optimize the feature extraction strategy of an artificial intelligence (AI) model. This framework enabled automatic segmentation of fracture regions and measurement of distal radius palmar tilt and radial inclination. The accuracy of the AI model in measuring radial inclination and volar tilt was validated, and the measurement time and average time gain rate of the AI model were compared to those of manual measurement. ResultsA total of 15,444 AP and lateral X-ray images of distal radius fractures were collected, and were divided into a training set (11,144 images, 5066 AP and 6078 lateral), a validation set (3700 images, 1840 AP and 1860 lateral), and an independent test set (600 images, 300 AP and 300 lateral) after preprocessing. In the measurement of 300 AP X-rays in the independent test set for radial inclination, when the degree error between AI measurement and manual measurement was <3° and <5°, AI measurement accuracy was 83% and 93%, respectively. In 300 lateral X-rays in the test set for palmar tilt, when AI measurements had an error of <3° and <5° compared to manual measurements, corresponding accuracy rate was 78% and 90%, respectively. For 50 X-ray images, AI measurement time was (1.37±0.05) min for radial inclination while manual measurement time was (22.57±2.52) min (P<0.001); in terms of palmar tilt, the AI measurement time was (1.33±0.14) min, shorter than (23.70±2.80) min for manual measurement time (P<0.001). Average time gain rates for manual and AI measurements were 93.93% and 94.39% respectively. ConclusionAn automatic measurement model for palmar tilt and radial inclination in distal radius fractures has been established, enabling more accurate and efficient assessment as well as providing a tool to support the quantitative evaluation of the efficacy of TCM manipulative reduction and large-sample clinical research.
8.Clinical Observation of Anshen Buxin Gao in Treating Coronary Heart Disease Complicated with Somatization Disorder After PCI
Yaozhong ZHOU ; Yanzhe WANG ; Wan CAI ; Wenjuan CAI ; Yan SHAO ; Yi SHEN ; Yan WANG ; Qiusheng SHEN
Chinese Journal of Experimental Traditional Medical Formulae 2026;32(13):197-204
ObjectiveTo observe the clinical efficacy of Anshen Buxin Gao in patients with coronary artery disease (CAD) complicated with somatization disorder after percutaneous coronary intervention (PCI), as well as its effect on heart rate variability (HRV). MethodsA total of 96 patients with somatization disorder after PCI were selected and randomized into control and treatment groups (48 cases). On the basis of standardized Western medical treatment for CAD, the control group received Dailixin, while the treatment group received Dailixin combined with Anshen Buxin Gao. The somatic symptom scale (SSS), generalized anxiety disorder 7-item scale (GAD-7), patient health questionnaire-9 (PHQ-9), and self-rating scale of sleep (SRSS) scores in both groups were recorded before and after treatment. The traditional Chinese medicine symptom efficacy, HRV, and incidence of adverse drug reactions were observed. ResultsA total of 90 patients completed the trial, encompassing 45 patients in the control group and 45 patients in the treatment group. Baseline characteristics between the two groups showed no statistically significant differences, indicating comparability. After treatment, both groups exhibited reductions in SSS, GAD-7, and PHQ-9 scores (P<0.05), and the treatment group outperformed the control group in alleviating somatic symptoms and anxiety-depression symptoms (P<0.05). The control group did not achieve a significant reduction in SRSS score, whereas the treatment group effectively lowered the SRSS score (P<0.05). Regarding traditional Chinese medicine symptom efficacy, the total response rate in the treatment group was 91.1% (41/45), which was higher than that (71.1%, 32/45) in the control group (Z=-2.663, P<0.05). Both groups improved HRV in patients with somatization disorder, and the treatment group showed greater improvement (P<0.05). There were no serious clinical adverse events during the study period. The incidence of adverse reactions in the treatment group was 6.7% (3/45), which was lower than that (14/45, 31.10%) in the control group (χ2=7.252, P<0.05). ConclusionThe addition of Anshen Buxin Gao to Dailixin therapy significantly alleviates the clinical symptoms and improves the sleep quality, treatment efficacy, and HRV in patients with CAD complicated with somatization disorder after PCI, while reducing the adverse effects associated with Dailixin alone. This approach demonstrates considerable clinical value and warrants further promotion.
9.Sequence polymorphism and evolutionary analysis of HLA-A, -B, and -C loci in the northern Han Chinese population
Wenqian SONG ; Wanzhen YU ; Suning BAI ; Liying WANG ; Linnan SHAO ; Shihang ZHOU ; Xiaohua LIANG
Chinese Journal of Blood Transfusion 2026;39(6):743-749
Objective: To characterize the sequence polymorphism of HLA-A, -B, and -C loci in the northern Han Chinese population and to evaluate their selection signals and phylogenetic patterns based on long-read sequencing data. Methods: A total of 408 unrelated healthy blood donors were enrolled. Long-read sequencing of HLA-A, -B, and -C loci was performed using the PacBio Sequel II platform. The Ewens-Watterson neutrality test, sliding-window nucleotide diversity (π) and Tajima′s D analyses were conducted, together with genetic distance heatmaps, principal coordinates analysis (PCoA), and maximum likelihood phylogenetic analysis to assess polymorphism distribution, selection signals, and phylogenetic structure across the three loci. Results: The analyzed sequence lengths for the HLA-A, -B, and -C loci were 3 257 bp, 3 794 bp, and 3 831 bp, respectively; the numbers of locus-specific sequence types were 44, 82, and 56, with corresponding locus-specific sequence type diversities of 0.905 2, 0.964 9, and 0.939 8, respectively. The Ewens-Watterson test showed no significant deviation from neutrality (P>0.05). Sliding-window analysis revealed elevated π and Tajima′s D values in exons 2 and 3 as well as in certain intronic regions of HLA-A and HLA-B, whereas HLA-C exhibited relatively lower overall diversity. Genetic distance heatmaps, PCoA, and phylogenetic analysis consistently showed clear clustering in HLA-A and HLA-C, while HLA-B displayed the highest phylogenetic heterogeneity. Conclusion: HLA-A, -B, and -C gene sequences in the northern Chinese Han population exhibit high levels of polymorphism and marked regional heterogeneity. HLA-B shows greater diversity, stronger signals of selection, and more complex phylogenetic structure compared with HLA-A and HLA-C.
10.Advances in antibody-drug conjugates in the treatment of urothelial carcinoma
Tianxiang ZHOU ; Haojie LIU ; Sihai SHAO
Journal of Modern Urology 2026;31(1):91-95
The conventional treatment strategies offer limited efficacy in advanced or recurrent cases of urothelial carcinoma.Antibody-drug conjugates(ADCs), as a novel type of targeted therapy, deliver cytotoxic agents directly to tumor cells with both high potency and specificity, making them an important tool in precision oncology.This review systematically summarizes the structural components of ADCs and their antitumor mechanisms, including targeted antigen internalization and bystander effect.It also highlights key clinical research findings of representative ADCs, such as nectin cell adhesion molecule 4, trophoblast cell surface antigen 2, and human epidermal growth factor receptor 2.Furthermore, the article addresses the current challenges in the application of ADCs, such as drug resistance, toxicity management, and high cost, while exploring the development of next-generation ADCs and their potential in combination with immunotherapy.Based on current evidence, this review aims to offer valuable insights to support the clinical application and future research of ADCs in the treatment of urothelial carcinoma.

Result Analysis
Print
Save
E-mail